女性冠心病：21 世纪的挑战。
Coronary heart disease in women: a challenge for the 21st century.
机构信息
Department of Clinical Cardiology, Instituto do Coração (InCor), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo/SP, Brazil.
出版信息
Clinics (Sao Paulo). 2010;65(1):99-106. doi: 10.1590/S1807-59322010000100015.
Abstract
Heart disease is the first killer of women in the modern era, regardless of age, race and of ethnicity, although its prevalence rises after menopause. Modern women have professional and housewife responsibilities, consume excess of fat and carbohydrates, smoke, do not exercise regularly and do not have enough time to rest. This situation leads to overweight, dyslipidemia, arterial hypertension, impaired glucose tolerance and diabetes. Women do not often participate in preventive studies and still undergo less intensive and invasive evaluation and treatment for chest pain when compared to men. However, the rate of coronary death is twice higher in women than in men after myocardial infarction and revascularization procedures. The objective of this review is to analyze the main gender differences regarding symptoms, diagnosis, management and prognosis of coronary heart disease and to discuss the influence of hormonal replacement therapy in the prevention of cardiovascular disease in postmenopausal women.
摘要
在现代社会，无论年龄、种族和民族如何，心脏病都是女性的第一大杀手，尽管其发病率在绝经后会上升。现代女性承担着职业和家庭主妇的双重责任，摄入过多的脂肪和碳水化合物，吸烟，不经常锻炼，也没有足够的休息时间。这种情况会导致超重、血脂异常、动脉高血压、糖耐量受损和糖尿病。女性通常不参与预防性研究，与男性相比，在胸痛方面接受的评估和治疗也不够深入和有创。然而，在心肌梗死和血运重建手术后，女性的冠状动脉死亡率是男性的两倍。本综述的目的是分析冠心病在症状、诊断、管理和预后方面的主要性别差异，并讨论激素替代疗法对绝经后女性预防心血管疾病的影响。
相似文献
1
Coronary heart disease in women: a challenge for the 21st century.女性冠心病：21 世纪的挑战。
Clinics (Sao Paulo). 2010;65(1):99-106. doi: 10.1590/S1807-59322010000100015.
2
Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.激素替代疗法用于心血管疾病一级预防试验的经验教训。
Curr Opin Cardiol. 2007 Sep;22(5):434-42. doi: 10.1097/HCO.0b013e328201cb7a.
3
Estrogen replacement therapy and outcome of coronary balloon angioplasty in postmenopausal women.
Am J Cardiol. 1998 Aug 15;82(4):409-13. doi: 10.1016/s0002-9149(98)00351-8.
4
Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?脂质与心血管疾病：这些研究结果及治疗方法对男性和女性同样适用吗？
Womens Health Issues. 1992 Summer;2(2):102-11; discussion 111-3. doi: 10.1016/s1049-3867(05)80278-6.
5
Hormone replacement therapy and stroke.激素替代疗法与中风
Curr Vasc Pharmacol. 2008 Apr;6(2):112-23. doi: 10.2174/157016108783955338.
6
Hormone replacement therapy in clinical cardiology.临床心脏病学中的激素替代疗法。
Cardiol Rev. 2000 Jan-Feb;8(1):57-64. doi: 10.1097/00045415-200008010-00010.
7
Heart disease in women.女性心脏病
Int J Fertil Womens Med. 2000 Nov-Dec;45(6):350-7.
8
Menopause and hormone replacement therapy.更年期与激素替代疗法。
Med Clin North Am. 1998 Mar;82(2):297-320. doi: 10.1016/s0025-7125(05)70608-8.
9
Where do we currently stand with advice on hormone replacement therapy for women?目前关于女性激素替代疗法的建议处于什么阶段？
Methodist Debakey Cardiovasc J. 2010;6(4):21-5. doi: 10.14797/mdcj-6-4-21.
10
Cardiovascular disease is preventable among women.心血管疾病在女性中是可预防的。
Expert Rev Cardiovasc Ther. 2010 Feb;8(2):175-87. doi: 10.1586/erc.09.125.
引用本文的文献
1
Sex difference in outcomes after coronary artery bypass grafting: follow-up data of the Netherlands Heart Registration.冠状动脉搭桥术后结局的性别差异：荷兰心脏注册研究的随访数据
Neth Heart J. 2025 Jan;33(1):26-33. doi: 10.1007/s12471-024-01920-5. Epub 2024 Dec 16.
2
Underrepresentation of women in cardiovascular trials- it is time to shatter this glass ceiling.心血管试验中女性参与人数不足——是时候打破这一玻璃天花板了。
Am Heart J Plus. 2022 Mar 5;13:100109. doi: 10.1016/j.ahjo.2022.100109. eCollection 2022 Jan.
3
Underrepresentation of women in cardiac imaging trials: A review.心脏成像试验中女性受试者比例不足：一项综述。
Am Heart J Plus. 2022 Feb 12;13:100102. doi: 10.1016/j.ahjo.2022.100102. eCollection 2022 Jan.
4
Sex-differences in outcome after off-pump coronary artery bypass grafting is age-dependent; data from the Netherlands Heart Registration.非体外循环冠状动脉旁路移植术后结局的性别差异与年龄有关；来自荷兰心脏注册的数据。
Heliyon. 2023 Dec 20;10(1):e23899. doi: 10.1016/j.heliyon.2023.e23899. eCollection 2024 Jan 15.
5
Do in-hospital outcomes of isolated coronary artery bypass grafting vary between male and female octogenarians?单纯冠状动脉旁路移植术在 80 岁以上男女患者中的院内转归是否存在差异？
Interact Cardiovasc Thorac Surg. 2022 Jun 1;34(6):958-965. doi: 10.1093/icvts/ivab281.
6
Ten-year risk of fatal cardiovascular disease and its association with metabolic risk factors among waste pickers in South Africa.南非拾荒者的致命心血管疾病 10 年风险及其与代谢风险因素的关系。
BMC Cardiovasc Disord. 2021 Jul 10;21(1):336. doi: 10.1186/s12872-021-02150-y.
7
Are the Early Postoperative Outcomes of Coronary Artery Bypass Grafting Surgery in Elderly Women Worse Compared to Men's?老年女性冠状动脉旁路移植手术的术后早期结果与男性相比更差吗？
Braz J Cardiovasc Surg. 2017 May-Jun;32(3):191-196. doi: 10.21470/1678-9741-2016-0071.
8
No Association of Coronary Artery Disease with X-Chromosomal Variants in Comprehensive International Meta-Analysis.在综合国际荟萃分析中，冠状动脉疾病与X染色体变异无关联。
Sci Rep. 2016 Oct 12;6:35278. doi: 10.1038/srep35278.
9
Type 2 diabetes and cardiovascular diseases: do they share a common soil? The Asian Indian experience.2型糖尿病与心血管疾病：它们有共同的根源吗？来自亚洲印度人的经验。
Heart Asia. 2012 Jan 1;4(1):69-76. doi: 10.1136/heartasia-2011-010081. eCollection 2012.
10
Female Gender and Differences in Outcome after Isolated Coronary Artery Bypass Graft Surgery: Does Age Play a Role?女性性别与单纯冠状动脉旁路移植术后结局差异：年龄起作用吗？
PLoS One. 2016 Feb 4;11(2):e0145371. doi: 10.1371/journal.pone.0145371. eCollection 2016.
本文引用的文献
1
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project.非阻塞性冠状动脉疾病女性的不良心血管结局：来自女性缺血综合征评估研究和圣詹姆斯女性心脏项目的报告。
Arch Intern Med. 2009 May 11;169(9):843-50. doi: 10.1001/archinternmed.2009.50.
2
Current diagnostic concepts to detect coronary artery disease in women.当前用于检测女性冠状动脉疾病的诊断概念。
Eur Heart J. 2008 Mar;29(6):707-17. doi: 10.1093/eurheartj/ehn047. Epub 2008 Feb 12.
3
Off-pump techniques benefit men and women and narrow the disparity in mortality after coronary bypass grafting.非体外循环技术对男性和女性均有益，且能缩小冠状动脉搭桥术后的死亡率差距。
Ann Thorac Surg. 2007 Nov;84(5):1447-54; discussion 1454-6. doi: 10.1016/j.athoracsur.2007.06.104.
4
Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry.急性冠状动脉综合征患者管理及预后的性别差异：来自AMIS Plus注册研究的20290例患者的结果
Heart. 2007 Nov;93(11):1369-75. doi: 10.1136/hrt.2006.106781.
5
Gender differences in chronotropic and hemodynamic responses during dobutamine-atropine stress echocardiography.多巴酚丁胺 - 阿托品负荷超声心动图检查期间变时性和血流动力学反应的性别差异
Echocardiography. 2007 Sep;24(8):843-50. doi: 10.1111/j.1540-8175.2007.00487.x.
6
Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.围绝经期女性心血管风险的管理：欧洲心脏病专家和妇科专家的共识声明
Eur Heart J. 2007 Aug;28(16):2028-40. doi: 10.1093/eurheartj/ehm296. Epub 2007 Jul 20.
7
Significant improvement in short-term mortality in women undergoing coronary artery bypass surgery (1991 to 2004).1991年至2004年期间接受冠状动脉搭桥手术的女性短期死亡率显著改善。
J Am Coll Cardiol. 2007 Apr 10;49(14):1552-8. doi: 10.1016/j.jacc.2006.08.068. Epub 2007 Mar 26.
8
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.绝经后激素治疗与心血管疾病风险随年龄及绝经年限的变化
JAMA. 2007 Apr 4;297(13):1465-77. doi: 10.1001/jama.297.13.1465.
9
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.2007年女性心血管疾病预防循证指南更新版
J Am Coll Cardiol. 2007 Mar 20;49(11):1230-50. doi: 10.1016/j.jacc.2007.02.020.
10
Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men.性别对运动和多巴酚丁胺负荷超声心动图风险分层的影响：4234名女性和6898名男性的长期死亡率
Eur Heart J. 2005 Mar;26(5):447-56. doi: 10.1093/eurheartj/ehi102. Epub 2005 Feb 1.
Zotero 插件